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The Centre for Oncology Education and Research Translation (CONCERT) 
Biobank 
Abstract 
The CONCERT Biobank was established as an open-access, multiple collection site biorepository 
designed to collect, process, store, retrieve and disseminate biological samples and health information 
for research projects following informed consent from participants diagnosed with cancer. Informed 
consent is obtained prior to surgery by either the nursing, medical or biobank staff. Tissues for 
biobanking are examined within the diagnostic anatomical pathology department of the participating 
hospital by qualified pathologists and tissues deemed in excess of diagnostic requirements are stored 
securely and anonymously by the biobank in anticipation of current and future research needs for broad 
and as yet unspecified cancer research nationally. 
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The CONCERT Biobank was established as an open-access, multiple collection site biorepository designed 
to collect, process, store, retrieve and disseminate biological samples and health information for research 
projects following informed consent from participants diagnosed with cancer. Informed consent is obtained 
prior to surgery by either the nursing, medical or biobank staff. Tissues for biobanking are examined 
within the diagnostic anatomical pathology department of the participating hospital by qualified patholo-
gists and tissues deemed in excess of diagnostic requirements are stored securely and anonymously by 




Any research work that will use the presently described 
bioresource in journal articles should conform to the 
CoBRA guideline [5] and be cited as follows:
‘Centre for Oncology Education and Research Transla-
tion Biobank (CONCERT), Australia / TCRC / Number 
of accesses / Date of last access. [BIORESOURCE]’
or as follows if the bioresource is not used but only 
referred to: ‘Centre for Oncology Education and Research 
Translation Biobank (CONCERT), Australia / TCRC / 
Number of accesses / Date of last access.’
More details at www.equator-network.org/
reporting-guidelines/cobra
Project description
The CONCERT Biobank was established and implemented 
in the South West Sydney and Illawarra Shoalhaven 
Local Health Districts, NSW, Australia, which previ-
ously had lacked any comprehensive cancer biobanking 
facilities to support their growing translational research 
programs.
The overarching aim of the CONCERT Biobank is to 
assist researchers in conducting large, population-based 
studies investigating the genetic, lifestyle and envi-
ronmental factors associated with cancer and to aid in 
 building and enabling research in daily clinical practice. 
This in turn will allow more rapid translation of research 
findings for the clinical benefit of patients. The CONCERT 
Biobank is also focussed on developing strategies for 
the establishment and maintenance of biobanks and 
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assisting in the implementation of more effective poli-
cies and procedures to embed biobanking into routine 
hospital practices [1]. 
The CONCERT Biobank policies and procedures have 
been formed and formulated according to the ISBER 
Best Practices for Repositories Guidelines [2], the OECD 
Best Practice Guidelines for Biological Resource Centres, 
the National Health and Medical Research Council 
Biobanks Information Paper [3], the Cancer Institute NSW 
A Comprehensive Review of Cancer-Related Biobanks in 
New South Wales Report and the Australian Breast Cancer 











The CONCERT Biobank is a non-profit entity, which is part 
of the CONCERT Translational Cancer Research Centre 
(TCRC). The CONCERT TCRC is a large multi-institutional 
consortium of universities (WSU, UNSW, and University of 
Wollongong), medical research institutes (Ingham Institute 
for Applied Medical Research and Illawarra Health and 
Medical Research Institute), hospitals and local health 
districts (South West Sydney and Illawarra/Shoalhaven), 
with many collaborative links spanning across NSW.
CONCERT Biobank collection centres include:
• Liverpool Hospital, NSW, Australia
• Bankstown-Lidcombe Hospital, , NSW, Australia
• Campbelltown Hospital, , NSW, Australia
• Braeside/Fairfield Hospital, NSW, Australia
• Camden Hospital, NSW, Australia
• Bowral Hospital, NSW, Australia
• Wollongong Hospital, NSW, Australia
• Wollongong Private Hospital, NSW, Australia
• Strathfield Private Hospital, NSW, Australia
• Sydney Southwest Private Hospital, NSW, Australia
Northern boundary: +/− x.x-33.52, 151.05 (Strathfield)
Southern boundary: +/− x.x-34.29, 150.25 (Bowral)
Eastern boundary: +/− x.x-33.55, 151.02 (Bankstown)
Western boundary: +/− x.x-34.03, 150.40 (Camden)
Temporal coverage
Start date 01 November 2012 to present; with collection, 
processing and storage of biospecimens indefinite.




• Participants deemed suitable for biobanking are 
identified by participating clinicians in their consult 
rooms or through multi-disciplinary team meetings.
• Potential participants are subsequently contacted and 
informed consent sought.
• If informed consent is obtained, biospecimens, includ-
ing fresh tumour and normal adjacent tissues, blood 
and other relevant bodily fluids, are collected at time 
of surgical resection.
• The fresh surgical specimen is examined within the par-
ticipating hospital by qualified pathologists and tissues 
deemed in excess of diagnostic requirements are sampled 
and stored securely and anonymously by the biobank.
• Demographic, pathological, clinical and biospecimen 
information are recorded electronically.
All standard work procedures by the CONCERT Biobank 
have been formulated based on several best practice guide-
lines, including the ISBER Best Practices for Repositories 
Guidelines [2]. 
Stabilization/preservation
Fresh tumour and normal adjacent tissue are stabilized 
on ice at 4°C before fixation in formalin or snap  freezing 
in liquid nitrogen. Blood specimens and other bodily 
fluids are stabilized at 4°C before long-term preservation 
at −80°C or −196°C with the exception of plasma samples 
which are stabilized in vacutainers of EDTA and stabilized 
at 4°C prior to long-term preservation.
Type of long-term preservation 
Please see section (3) Bioresource description, Biospecimen 
type for details.
All biospecimens and information are stored securely 
and anonymously.
Storage temperature 
Please see section (3) Bioresource description, Biospecimen 
type for details.
Shipping temperature from patient/source to 
preservation or research use
Biospecimens are transported using temperature-controlled, 
cold chain solutions. Depending on the biospecimen type 
to be transported and the transportation logistics, several 
options may be available including: 
• Controlled ambient: +15°C to +25°C
• Refrigerated: +2°C to +8°C
• Frozen: −20°C
• Deep frozen: −70°C – dry ice
• Packed on liquid nitrogen: −196°C
Shipping temperature from storage to research use
Biospecimens are transported using temperature-controlled, 
cold chain solutions. Depending on the biospecimen type 
to be transported and the transportation logistics, several 
options may be available including: 
Caixeiro et al: The Centre for Oncology Education and Research Translation (CONCERT) Biobank Art. e3, p.  3 of 5 
• Controlled ambient: +15°C to +25°C
• Refrigerated: +2°C to +8°C
• Frozen: −20°C
• Deep frozen: −70°C – dry ice
• Packed on liquid nitrogen: −196°C
The CONCERT Biobank arranges packaging and shipping 
of the biospecimens with the courier, and arranges for the 
invoice to be sent and paid for by the researcher.
Quality assurance measures
The quality assurance measures that have been imple-
mented by the CONCERT Biobank include:
• Implementation of standard work procedures (SWPs)
• Personnel training; documented and updated, if 
required, on a periodic basis
• Documentation of modifications or revisions of SWPs 
and risks assessments (RAs)
• Maintenance of records pertaining to biospecimens, 
equipment, and consumables
The quality control measures implemented by the 
CONCERT Biobank include:
• Verification of biospecimens by a pathologist, with 
tumour type, grade and cellular homogeneity rou-
tinely reported.
• Validation of processing methods of biospecimens via 
literature reviews, end user feed-back and/or labora-
tory quality control results
• Internal audits, including pre-audit checklists
Source of associated data 
Sources of associated data include:
• Hospital medical and pathology records
• Local health district and NSW Cancer registries
• Attending clinicians consult rooms
• Participants
Ethics Statement
Ethics approval (HREC/14/LPOOL/152) was obtained from 
the South Western Sydney Local Health District HREC, NSW, 
Australia, 01 November 2012. All collection sites have site 
specific ethics approvals. Ethics approval for the collection, 
processing and storage of biospecimens is indefinite. 
Constraints






The Centre for Oncology Education and Research Translation 
Biobank.
Bioresource acronym: CONCERT Biobank.
Bioresource location
The central site of the CONCERT Biobank is located at the 
Ingham Institute for Applied Medical Research, 1 Campbell 
Street, Liverpool, NSW, 2170, Australia, with collection 
nodes across NSW.
Bioresource contact

















Disease status of patients/source
Cancer.
Clinical characteristics of patients/source
• Age: all ages
• Gender: males and females
• Treatment information: yes 
• Inclusion criteria: ability of participant to give informed 
consent 
• Stage of the disease at time of collection: Biospecimens 
are collected at the time of surgical resection
Size of the bioresource 
• Over 500 participants as at 25 September 2015
• Ongoing recruitment of approximately 220 partici-
pants per annum
• Collection of biospecimens is ongoing and indefinite
Vital state of patients/source
Alive.
Clinical diagnosis of patients/source
Cancer.
Pathology diagnosis
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Biospecimen type 
A summary of the biospecimen characteristics is provided 
below (Table 1).
Release date
The date at which biospecimens have been available for 
applications is 2014.
Access criteria
Biospecimens collected by the CONCERT Biobank are 
made available to researchers on the provision that use 
of specimens are for scientifically valid and ethically 
approved research projects. 
Researcher access entails search facilities which allow for 
researchers to search biospecimen type and availability stored 
in the CONCERT Biobank using a link from the CONCERT 
TCRC website to the Biobank’s database, which is currently 
still under development. All biospecimens and information 
are stored securely and de-identified however they are re-
identifiable to CONCERT Biobank personnel who have signed 
confidentially agreements. Search facilities on the database 
protect all identifiable information of the participant. 
Currently, as the CONCERT Biobank is still in the progress 
of developing and implementing its database, researchers 
can request the use of biospecimens by contacting the 
CONCERT Biobank manager through the Ingham Institute 
for Applied Medical Research’s Biobank page, https:// 
inghaminstitute.org.au/content/concert-biobank.
Researchers seeking to use CONCERT Biobank specimens 
are required to formally apply using a prescribed applica-
tion form. The application form, along with the researcher’s 
institutional Ethical approval for the project, is submitted 
to the CONCERT Biobank manager who forwards the appli-
cation to the CONCERT Biobank’s scientific advisory com-
mittee (SAC) for assessment. The SAC committee rates all 
proposals based on its scientific aims, feasibility of study, 
credentials in type of research, justification for amount of 
material requested and overall scientific merit. If the appli-
cation is approved by the SAC then a Material Transfer 
Agreement (MTA) is issued to the researcher. 
An MTA is entered into in order to transfer CONCERT 
Biobank material to another organisation (commonly 
another university or research institution) for the purposes 
of that organisation’s own research. The MTA governs the 
transfer of material, including data, between the organisa-
tions and defines the rights and obligations of each in rela-
tion to custodianship; use of the biospecimens; and data 
arising from such use and any modifications or derivatives of 
the material. The CONCERT Executive Committee reviews all 
MTAs received by the CONCERT Biobank. No biospecimens 
are sent until the MTA has been approved by the CONCERT 
Executive Committee and signed by both organisations. 
Once receipt of the signed MTA has been received by the 
CONCERT Biobank, then the biospecimens will be packaged 
and shipped to the researcher, at the researcher’s expense. 
(4) Reuse potential
The CONCERT Biobank does not request return of bio-
specimens other than research results. Validated research 
results arising from the use of biobank specimens such as 
expression levels of cancer biomarkers or emerging cancer 
proteins are requested to be reported back to the biobank 
and are recorded in the database to be made available to 
future researchers to reference and access. 
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Biospecimen Type Biospecimen Processing Number of Aliquots Size(mm)/Volume (ml) Storage Type
Tumour and normal 
adjacent tissue
Fresh frozen tumour and 
normal adjacent tissue




Haematoxylin and Eosin 
cryosections
2–4 N/A 21°C
Tissue arrays N/A 21°C
Peripheral blood Whole blood 2 0.5 ml 21°C /−80°C
Plasma 4 0.5 ml −80°C
Serum 4 0.5 ml −80°C
Buffy Coat 2 0.5 ml −196°C
Bodily fluids Cavitron Ultrasonic Surgical 
Aspirator (CUSA) fluid
4–6 50 ml −80°C
Cerebrospinal fluid 2 0.5 ml −80°C
Demographic data N/A N/A N/A N/A
Pathological data
Clinical data
Table 1: Summary of biospecimen characteristics.
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